Alli, the over-the-counter weight loss drug manufactured by GlaxoSmithKline and its prescription counterpart Xenical, manufactured by Roche, are being investigated by the FDA after more than two dozen adverse event reports have associated the drugs with liver injury.
Alli contains half the dose of orlistat than the prescription drug Xenical is designed to block fat absorption in the intestines. Xenical was approved for use in 1999 while Alli appeared on the market in 2007.
Admitted to practice law in all federal multidistrict litigation courts, the California State Bar and the Florida Bar. His philosophy is to provide aggressive, quality representations and seek fair compensation for individuals and their families who have suffered injury, death, or sexual abuse.
Comments for this article are closed.